Target intelligence / Profile preview

microRNA 519b (miR-519b)

Target
miR-519b
Molecular classification
MicroRNA, Non-coding RNA, Member of the C19MC microRNA cluster
01

Overview

microRNA 519b is a small, non-coding RNA of approximately 22 nucleotides, encoded within the primate-specific C19MC miRNA gene cluster on chromosome 19. It acts as a post-transcriptional regulator by binding target mRNAs, most notably repressing translation of the oncogenic RNA-binding protein HuR, thereby functioning as a tumor suppressor in several cancers by inhibiting cell proliferation and tumorigenesis[1][2]. The expression of miR-519b and other C19MC cluster members is implicated in cancer, with variable roles that can include both tumor suppression and oncogenic activity depending on cellular context and tumor type. miR-519b is not a receptor, enzyme, transporter, or conventional therapeutic target, but dysregulation of its expression is relevant for cancer biology and potentially as a diagnostic or prognostic biomarker[1][2][3].

Other names
hsa-mir-519bMIRN519Bmir-519bMIR519B
02

Mechanism of action

Binds to complementary sequences in the 3′ untranslated region (UTR) of target mRNAs to repress translation and/or induce mRNA decay via incorporation into the microRNA-induced silencing complex (miRISC) Specifically lowers translation of the RNA-binding protein HuR, suppressing tumor growth without reducing HuR mRNA

03

Biological functions

Post-transcriptional gene regulationInhibition of mRNA translationRegulation of cell proliferationRegulation of tumorigenesisModulation of RNA-binding proteins (e.g., HuR)Cellular differentiation
04

Disease associations

Cancer (including hepatocellular carcinoma, ovarian, lung, kidney, and potentially other solid tumors)Tumor suppression (by repressing HuR)Potential oncogenic roles when overexpressed in certain cancer subtypes
05

Safety considerations

None reported as a therapeutic target; microRNAs generally pose challenges related to off-target effects and delivery if considered for therapy
06

Biomarkers

Downregulation in tumors may serve as a biomarker for poor prognosis in some cancersElevated miR-519b expression as a marker for specific molecular subclasses (e.g., C2/C19MC in HCC)

Beyond the preview

Go deeper on microRNA 519b (miR-519b).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 519b (miR-519b).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call